Key Takeaways
- Volume-led growth despite disruptions: Revenue grew 9% YoY and EBITDA 29% YoY as the company deliberately pushed volumes, even at a slight margin compromise, to gain market share and lift asset utilization.
- Geopolitics and freight created a margin squeeze: A spike in export freight rates, a shift in destination mix toward longer-haul US routes, and the sudden shutdown of the Middle East market for energy applications combined to pressure profitability and inflate working capital.
- Two new long-term contracts validate the partnership model: A $150 million agrochemical supply agreement and a backward-integration deal with a global chemical major were signed, with management highlighting a repeat contract from an existing partner as powerful validation of its value proposition.
- Zone IV commissioning is delayed but the EBITDA potential is intact: A 35% drop in contract labour availability has pushed project timelines by 3–4 months, meaning the ₹300–450 crore incremental EBITDA may now arrive 6–7 months later than originally planned.
- What to watch next quarter: Whether the full impact of Middle East disruptions on energy volumes materializes as expected, any stabilization in freight rates, and the pace of Zone IV commissioning starts.
Volume Strategy & Operating Performance
- Deliberate volume push: Management has made a conscious choice to improve utilization levels across all existing assets, accepting a slight compromise on margins to drive volumes and gain market share. Capacity utilization is upwards of 80–85%, with further upside possible in select chains like DCB and ethylation.
- Energy application disruption: Volumes in the energy segment fell 4% QoQ, driven primarily by lower exports to the Middle East as geopolitical disruptions effectively shut that market. The company partially offset this by rerouting product to other geographies, and management warned the full impact will be felt in Q1 FY27.
- Non-energy portfolio mixed: Agrochemicals showed steady volume growth but margin pressure continued, driven by Chinese industry dynamics. Dyes, pigments and paints were relatively stable, though the dye segment appears to be slowing after peaking in the prior two quarters. Polymers are in a strong growth phase driven by EV market demand, while MPDA underperforms due to heavy competition from China.
- Freight cost spike: Other expenses rose significantly, driven by a combination of higher unit freight rates (escalating from mid-February), increased export volumes (exports hit 57% of sales), and a destination mix shift toward the US, which carries a 2–3 month voyage time versus 7–10 days for the Middle East.
Suyog Kotecha: "I think improving utilization levels of all of our existing assets has been a deliberate strategy. And I think we have pushed volumes sometimes even at the expense of a slight compromise on the margins."
Zone IV & Capex Execution
- Labour shortage delays commissioning: A 35% reduction in contract labour availability in the region, driven by a combination of LPG-related impacts and election-related migration, has delayed the labour-intensive last-mile pipeline connectivity work. Management targets catching up on the 3–4 month delay.
- Commissioning sequence: The calcium chloride plant is already under operation with commercial runs done and will ramp to full capacity over 3–4 weeks. The multipurpose plant and PEDA plants are under commissioning trials and should come on stream soon. The remaining five chemistry blocks will commission throughout FY27, with initial revenue expected from Q2 FY27.
- EBITDA potential delayed, not lost: Management confirmed no change to the EBITDA potential from the MPP, Zone IV, or the UPL JV. However, the ₹300–450 crore incremental EBITDA that was expected may now be delayed by 6–7 months, potentially pushing the full realization beyond FY28.
- FY27 capex guidance: Expected at ₹700–800 crore, with a significant portion allocated to completing Zone IV and the new long-term contract, and approximately ₹150 crore for asset maintenance. Net debt is anticipated to decline in the current year given the lower capex intensity.
- Augene JV on track: The Superform joint venture is expected to commission within the June/July timeframe and ramp to full utilization within the current financial year, with an initial focus on agrochemicals and coatings end markets. The JV should operate at a slightly better margin profile than AIL's current levels, with EBITDA reported separately as a 50-50 JV.
Suyog Kotecha: "Our target as a management team still remains on how to do catch up even with the 3 to 4 months of delay. But at the same time, we are transparent in communicating in terms of how are we progressing against our initiatives, right?"
Balance Sheet & Working Capital
- Working capital expansion: Net working capital increased by ₹250–300 crore in the latter part of Q4, driven by a significant elevation in raw material prices and a higher export mix. Export receivables carry optically longer days than domestic, and US-bound shipments with 2–3 month voyage times tie up more capital than nearer markets.
- Debt optics distorted by timing: Reported net debt of ₹4,300 crore includes a ₹600 crore one-off: a term loan disbursed in the last days of March that could not be deployed to reduce debt before the quarter-end due to holidays. The bulk of this cash was used to liquidate debt in the first week of April.
- Inventory in transit: Part of the inventory increase reflects materials exported from India that are on the seas in transit to customers, where revenue is not recognized until delivery. Some element of raw material price impact in the latter part of the last month also contributed.
- FX revaluation loss: An unhedged FX loan of $87 million generated a revaluation loss as the rupee depreciated ₹5 from December 31 to March 31. This exposure will be repaid over the next 8 years, and the growing export portfolio will act as a natural hedge, though accounting gains are recognized only when materialized while losses are booked immediately.
- Crude price sensitivity: If crude stays at the current $100–110/barrel level or corrects, working capital requirements should reduce. If crude rises to $140–150/barrel, working capital will increase further and strain the balance sheet.
MMA Market Dynamics
- Multiple cross-currents: The MMA market is being shaped by several factors that vary by region: naphtha-gasoline spread volatility, absolute pricing levels, elevated raw material costs (aniline and methanol), and the company's ability to optimize volumes and spreads. Management sees no conclusive trend until the Middle East situation is directionally settled.
- Middle East market shut: Shipments to the Middle East are currently physically impossible. If the situation stabilizes, volume requirements could dramatically increase as the region has been running dry of product for 6–8 weeks. If not settled in the next two months, there will be a certain impact on MMA volumes to the region.
- US and Europe flows: Shipments to the US have been consistent, and shipments to Europe are now starting. The company focuses on working closely with customers to understand affordability and dynamically allocates product to regions given the volatile geopolitical situation.
- Octane booster market limited: The market segment where pricing is not linked to the crack spread and refineries must add MMA regardless of pricing is relatively small. MMA is not the only octane booster available; multiple alternatives exist with significantly lower performance ranges, meaning pricing economics must factor into customer decision-making.
Suyog Kotecha: "I do not think there is any conclusive trend at this point in time, which we can draw. And I do not think we will reach a stability until the situation in the Middle East is kind of directionally at least settled."
Long-Term Contracts & Partnerships
- Two new contracts signed: A backward-integration initiative with a leading global chemical company involves capex of ₹200–250 crore and carries a residual 15-year contract period with an additional fixed margin. A separate $150 million multiyear supply agreement with a global agrochemical innovator for a critical intermediate runs through March 31, 2030, and requires no incremental capex.
- Repeat contract as validation: Management highlighted that a repeat long-term contract from a global major in the last quarter serves as significant validation of Aarti's value proposition: the ability to deliver extremely reliable and safe operations in complicated chemistries in the most competitive manner.
- Existing contract status: Of the three historical long-term contracts, the advanced polymer intermediate continues as per contractual terms with secure and predictable earnings. The MMA-linked contract met target volumes at a yearly level in the last calendar year, though monthly or quarterly volumes may fluctuate. The agrochemical intermediate contract has volume conditions being met but faces margin pressure compared to original expectations.
- Partnership momentum increasing: Management stated that momentum is increasing as global players look for more robust and secure supply chains, with many conversations expected to proceed and conclude in the coming financial year. The intention is for such partnerships to contribute much more meaningfully to the business and help improve earnings quality.
Suyog Kotecha: "I think it is one thing to get a long-term contract. But if the same major comes back to you with a repeat long-term contract, that also gives you a significant validation of the value proposition that you are putting up in this partnership, and that was very heartening to see."
China Dynamics & Margin Recovery
- Anti-involution stance emerging: China's increasing regulatory scrutiny on nitration chemistry assets, with more constraints being placed on hazardous operations and a push toward continuous operations and additional safety measures, is expected to force out smaller, inefficient operators over time. Benefits to products related to PNCB in the NCB chain are expected from Q1 FY27 onwards.
- Agrochem margin recovery contingent on China: The biggest driver for recovering margins in agrochemicals is how the Chinese industry evolves. The narrative being observed, if it persists and becomes more broad-based, could lead to margin recovery, but management is waiting for a firmer trend before making conclusive commentary.
- Select pricing recovery underway: Pricing recovery is already happening in select pockets like NCB and DCB. If China continues its anti-involution stance, the recovery should become more broad-based over the course of the next few quarters.
- Raw material pass-through: On the agrochemical side, management expects to be able to fully pass on raw material price rises over the course of the next 3–6 months, provided there is stability on the raw material side.
Suyog Kotecha: "The narrative that we are hearing what we are seeing, I think if that persists and that becomes much more broad-based, we might see a recovery in the margin. But I think we wait to see a firmer trend to make a conclusive commentary on the segment."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Zone IV commissioning | Calcium chloride and MPP under trials; remaining 5 chemistry blocks to follow | Calcium chloride and MPP in Q1 FY27; all blocks throughout FY27 |
| Zone IV initial revenue | Revenue contribution to begin | Q2 FY27 |
| Zone IV revenue potential | Hit previously communicated range | Over course of 2 years |
| Incremental EBITDA from Zone IV/MPP/UPL JV | ₹300–450 crore, delayed by 6–7 months from original timeline | Potentially beyond FY28 |
| FY27 capex | ₹700–800 crore | FY27 |
| Net debt | Decline from current levels | FY27 |
| Cash flow vs. capex | Cash flow expected to exceed planned capex | FY27 |
| Augene JV commissioning | Commission and ramp to full utilization | June/July 2026; full utilization within FY27 |
| Recycling JV commissioning | Commission within calendar year; meaningful contribution may take time | CY26 |
| Tax rate | 9% to 15% range | Going forward |
| China anti-involution benefit | Benefits to PNCB-related products in NCB chain | From Q1 FY27 onwards |
| Raw material price pass-through (agro) | Full pass-through, conditional on raw material stability | Next 3–6 months |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Revenue | ₹2,422 cr, +9% YoY |
| EBITDA | ₹342 cr, +29% YoY |
| Profit after tax | ₹137 cr, +43% YoY |
| Full-year FY26 revenue | ₹9,018 cr, +12% YoY |
| Full-year FY26 EBITDA | ₹1,172 cr, +15% YoY |
| Full-year FY26 PAT | ₹419 cr, +27% YoY |
| FY26 capex | ₹1,125 cr, in line with guidance |
| FY27 capex guidance | ₹700–800 cr |
| Net debt | ₹4,300 cr, net debt-to-EBITDA at 3.6x |
| Energy application revenue share | ~40% of total revenue |
| Energy application volumes | -4% QoQ, impacted by lower exports to Middle East |
| Middle East revenue exposure | ~9–10% of total revenue on yearly average, dominantly in energy |
| Exports share of revenue | 57% of total revenue in Q4 |
| FX revaluation loss on long-term foreign currency loan | ₹39 cr, on $87 mn unhedged exposure |
| New multiyear supply agreement | $150 mn with global agrochemical innovator, extending through March 31, 2030 |
| Zone IV project delay | 3–4 months due to contract labour constraints |